Atlas Trials

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Clinical trial NCT00534248 · COMPLETED

Trial details

NCT number
NCT00534248
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Shingles
Start date
2007-10-01
Primary completion
2010-01-01
Enrollment
22439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.